Her condition developed more quickly than what Meige's syndrome's regular pattern is.
Meige's syndrome is a kind of focal dystonia disease, and it was first reported by French neurologist Meige in 1910.
Meige's syndrome usually starts to appear when people are 50 to 60, but there are teenage patients as well.
When Meige's syndrome's initial symptoms are not typical, it should be differentiated from xeroma[5-6].
Primary Meige's syndrome's nosogenesis is unclear; while secondary Meige's syndrome could be related to the upper brain stem and abnormal basal ganglia dopamine receptor hypersensitivity, the hyperactive cholinergic nervous system (e.g., basal ganglia), low Gamma-aminobutyric Acid (GABA) function.
Currently, the drugs for Meige's syndrome include anticholinergics (e.g.
Below, a patient who developed Meige's syndrome due to quetiapine augmentation to lithium and tardive blepharospasm due to olanzapine augmentation to lithium at different episodes of the illness is presented.
(13.) Fukui H, Murai T Marked Improvement of Meige's syndrome with olanzapine in a schizophrenic patient.
Facial dystonias and hyperkinetic states (hemifacial spasm, essential blepharospasm, and Meige's syndrome) can also occur.
Lastly, Meige's syndrome is a rare disorder characterized by blepharospasm and involuntary contractions of the muscles in the jaw and tongue (oromandibular dystonia).